Faculty, Staff and Student Publications
Open-access journal articles from UTHealth GSBS faculty, staff and students.
Submissions from 2024
Differential Treatment Effects of Subgroup Analyses in Phase 3 Oncology Trials From 2004 to 2020, Alexander D Sherry, Andrew W Hahn, Zachary R McCaw, et al.
Differential Treatment Effects of Subgroup Analyses in Phase 3 Oncology Trials From 2004 to 2020, Alexander D Sherry, Andrew W Hahn, Zachary R McCaw, et al.
Improving the Clinical Meaning of Surrogate Endpoints: An Empirical Assessment of Clinical Progression in Phase III Oncology Trials, Alexander D Sherry, Timothy A Lin, Zachary R McCaw, et al.
Off-Protocol Radiation Therapy in Phase 3 Metastatic Solid Tumor Trials, Alexander D Sherry, Timothy A Lin, Zachary R McCaw, et al.
Lost in the Plot: Missing Visual Elements in Kaplan-Meier Plots of Phase III Oncology Trials, Alexander D Sherry, Pavlos Msaouel, Ramez Kouzy, et al.
Postprogression Therapy and Confounding for the Estimated Treatment Effect on Overall Survival in Phase III Oncology Trials, Alexander D Sherry, Pavlos Msaouel, Timothy A Lin, et al.
Increasing Power in Phase III Oncology Trials With Multivariable Regression: An Empirical Assessment of 535 Primary End Point Analyses, Alexander D Sherry, Adina H Passy, Zachary R McCaw, et al.
Association of Preoperative Lung Function with Complications after Lobectomy Using Race-Neutral and Race-Specific Normative Equations, Ajay Sheshadri, Ravi Rajaram, Aaron Baugh, et al.
Intratumoral Injection of Immunotherapeutics: State of the Art and Future Directions, Rahul A Sheth, Eric Wehrenberg-Klee, Sapna P Patel, et al.
Escalated-Dose Radiotherapy for Unresected Locally Advanced Pancreatic Cancer: Patterns of Care and Survival in the United States, Christopher Shi, Brian De, Hop S Tran Cao, et al.
Tert Activation Targets DNA Methylation and Multiple Aging Hallmarks, Hong Seok Shim, Jonathan Iaconelli, Xiaoying Shang, et al.
Enhanced CTLA-4 Blockade Anti-tumor Immunity With APG-157 Combination in a Murine Head and Neck Cancer, Daniel Sanghoon Shin, Saroj Basak, Mysore S Veena, et al.
Chimeric Oncolytic Adenovirus Evades Neutralizing Antibodies From Human Patients and Exhibits Enhanced Anti-Glioma Efficacy in Immunized Mice, Dong Ho Shin, Hong Jiang, Andrew G Gillard, et al.
Self-Management Intervention Improves Patient Adherence to Swallowing Exercises During Radiation for Head and Neck Cancer, Eileen H Shinn, Adam S Garden, Minxing Chen, et al.
Iterative Patient Testing of a Stimuli-Responsive Swallowing Activity Sensor to Promote Extended User Engagement During the First Year After Radiation: Multiphase Remote and In-Person Observational Cohort Study, Eileen H Shinn, Adam S Garden, Susan K Peterson, et al.
Protein-Centric Omics Analysis Reveals Circulating Complements Linked to Non-viral Liver Diseases As Potential Therapeutic Targets, Yingzhou Shi, Hang Dong, Shiwei Sun, et al.
Targeting PRMT3 Impairs Methylation and Oligomerization of HSP60 to Boost Anti-tumor Immunity by Activating cGAS/Sting Signaling, Yunxing Shi, Zongfeng Wu, Shaoru Liu, et al.
survivalContour: Visualizing Predicted Survival via Colored Contour Plots, Yushu Shi, Liangliang Zhang, Kim-Anh Do, et al.
Decoding the Molecular Symphony: Interactions Between the m6A and p53 Signaling Pathways in Cancer, Rachel Shoemaker, Mo-Fan Huang, Ying-Si Wu, et al.
Gravity- vs Wall Suction-Driven Large-Volume Thoracentesis: A Randomized Controlled Study, Samira Shojaee, Jasleen Pannu, Lonny Yarmus, et al.
Azacitidine, Venetoclax, and Gilteritinib in Newly Diagnosed and Relapsed or Refractory FLT3-Mutated AML, Nicholas J Short, Naval Daver, Courtney D Dinardo, et al.
Inotuzumab Ozogamicin for the Treatment of Adult Acute Lymphoblastic Leukemia: Past Progress, Current Research and Future Directions, Nicholas J Short, Elias Jabbour, Nitin Jain, et al.
A Phase 1/2 Study of Mini-Hyper-Cvd Plus Venetoclax in Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia, Nicholas J Short, Elias Jabbour, Nitin Jain, et al.
Dose-Dense Mini-Hyper-CVD, Inotuzumab Ozogamicin and Blinatumomab Achieves Rapid MRD-Negativity in Philadelphia Chromosome-Negative B-cell Acute Lymphoblastic Leukemia, Nicholas J Short, Elias Jabbour, Trevor Jamison, et al.
Decitabine, Venetoclax, and Ponatinib for Advanced Phase Chronic Myeloid Leukaemia and Philadelphia Chromosome-Positive Acute Myeloid Leukaemia: A Single-Arm, Single-Centre Phase 2 Trial, Nicholas J Short, Daniel Nguyen, Elias Jabbour, et al.